For patients with rare diseases, the path to diagnosis can be long and difficult. But, as a new policy paper from the European Alliance for Patient Access notes, that’s only one of several hurdles that patients face.
After a four-year campaign, the National Rheumatoid Arthritis Society and the British Society for Rheumatology have succeeded in levelling the playing field for people with rheumatoid arthritis in England and Wales.
World leaders are squaring off on a complex topic: whether to temporarily waive intellectual property rights for COVID-19 vaccines. The so-called “TRIPs wavier,” debated through the World Trade Organization, could have both short- and long-term consequences for patients.